Recent advances in transdermal drug delivery system

International Journal of PharmTech Research

Volumn 2, Issue 1, 2010, Pages 68-77

  Bhowmik, Debjit ^a   Chiranjib, ^d   Chandira, Margret ^b   Jayakar, B ^b   Sampath, K P ^c  

^a Rajiv Gandhi College of Pharmacy   (India)

^b VINAYAKA MISSION S RESEARCH FOUNDATION DEEMED TO BE UNIVERSITY   (India)

^c Department of Microbiology   (India)

^d NONE

Author keywords

Transdermal drug delivery system

Indexed keywords

4 DIMETHYLAMINOBENZOIC ACID 2 ETHYLHEXYL ESTER; 5,5 DIMETHYL 1,3 CYCLOHEXANEDIONE; CONTRACEPTIVE AGENT; FENTANYL; GLYCERYL TRINITRATE; HALOPERIDOL; LIDOCAINE; LIMONENE; LINALOOL; MENTHONE; NICOTINE PATCH; OXYBUTYNIN; SCOPOLAMINE; TAMOXIFEN; TESTOSTERONE;

ANGINA PECTORIS; CANCER PAIN; CHRONIC PAIN; CIGARETTE SMOKING; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG RELEASE; DRUG TOLERABILITY; ELECTROPORATION; HORMONE SUBSTITUTION; HUMAN; IN VITRO STUDY; IONTOPHORESIS; MOTION SICKNESS; NAUSEA; NONHUMAN; PAIN; PARKINSON DISEASE; PHYSICAL CHEMISTRY; REVIEW; SKIN DISEASE; SKIN IRRITATION; SKIN SENSITIZATION; TOBACCO DEPENDENCE; TRANSDERMAL PATCH; URINE INCONTINENCE;

EID: 77953458284     PISSN: None     EISSN: 09744304     Source Type: Journal    
DOI: None     Document Type: Review

References (28)

1. nd edi, Marcel Dekker, New York. pp. 524-552.
2. Aquil, M., Sultana, Y. and Ali, A. (2003). Matrix type transdermal drug delivery systems of metoprolol tartrate: In vitro characterization. Acta Pharm, 53: 119-125.
3. Ramesh, G., Vamshi Vishnu, Y., Kishan, V and Madhusudan Rao, Y. (2007). Development of nitrendipine transdermal patches: in vitro and ex vivo characterization. Current Drug Del, 4: 69-76.
4. Singh, J., Tripathi, K.P. and Sakia, T.R. (1993). Effect of penetration enhancers on the in vitro transport of ephedrine through rat skin and human epidermis from matrix based transdermal formulations. Drug Dev. Ind. Pharm, 19: 1623-1628.
5. Valenta, C. and Almasi-Szabo, I. (1995). In vitro diffusion studies of ketoprofen transdermal therapeutic system. Drug Dev.Ind. Pharm, 21:1799-1805.
6. Krishna, R. and Pandit, J.K. (1994). Transdermal delivery of propranolol. Drug Dev.Ind. Pharm, 20: 2459-2465.
7. Aqil, M., Zafar, S., Ali, A. and Ahmad, S. (2005). Transdermal drug delivery of labetolol hydrochloride: system development, in vitro; ex vivo and in vivo characterization. Curr Drug Deliv, 2(2): 125-31.
8. Shin, S. and Lee, H. (2002). Enhanced transdermal delivery of triprolidine from the ethylene-vinyl acetate matrix. Eur. J. Pharm. Biopharm, 54: 161-164.
9. th edi, Pharmaceutical Press, London (U.K), pp. 1055.
10. August, B.J., Blake, J.A. and Hussain, M.A. (1990). Contributions of drug solubilization, partitioning, barrier disruption and solvent permeation to the enhancement of skin permeation of various compounds with fatty acids and amines. Pharm. Res, 7: 712-718.
11. Cho,Y.J. and Choi, H.K. (1998). Enhancement of percutaneous absorption of ketoprofen: effect of vehicles and adhesive matrix. Int. J. Pharm.169: 95-104.
12. Kim, J., Cho, Y.J. and Choi, H. (2000). Effect of vehicles and pressure sensitive adhesives on the permeation of tacrine across hairless mouse skin. Int. J. Pharm. 196: 105-113.
13. Panchangula, R., Salve, P.S., Thomas, N.S., Jain, A.K. and Ramarao, P. (2001). Transdermal delivery of naloxone: effect of water, propylene glycol, ethanol and their binary combinations on permeation through rat skin. Int. J. Pharm, 219: 95-105.
14. Manvi, F.V., Dandagi, P.M., Gada, A. P., Mastiholimath, V.S. and Jagadeesh, T. (2003). Formulation of a transdermal drug delivery system of ketotifen fumarate. Indian J. Pharm. Sci, 65(3): 239-243.
15. Mollgaard, B. and Hoelgaard, A. (1983). Permeation of estradiol through the skin-effect of vehicles. Acta Pharm. Suec, 20: 443-450.
16. Barry, B.W. (1987). Mode of action of penetration enhancers in human skin J. Control. Release, 6: 85-97.
17. Rowe, E.S. (1985). Lipid chain length and temperature dependence of ethanolphosphatidylcholines. Biochem. Biophys. Acta, 813: 321-330.
18. Kurihara-Bergstrom, T., Knutson, K., Denoble, L.J. and Goates, C.Y. (1990). Percutaneous absorption enhancement of an ionic molecule by ethanol-water systems in human skin. Pharm. Res. 7:762-766.
19. Kim, Y.H., Ghanem. A.H., Mahmoud, H.and Higuchi, W.I. (1992). Short chain alkanols as transport enhancers for lipophilic and polar/ionic permeants in hairless mouse skin: Mechanism(s) of action. Int. J. Pharm, 80: 17-31.
20. Arora, P. and Mukherjee, B. (2002). Design, development, physicochemical, and in vitro and in vivo evaluation of transdermal patches containing diclofenac diethylammonium salt. J Pharm Sci, 9: 2076-2089.
21. Devi, K., Saisivum, S., Maria, G.R. and Deepti, P.U.( 2003). Design and evaluation of matrix diffusion controlled transdermal patches of verapamil hydrochloride. Drug Dev Ind Pharm, 5: 495-503.
22. Kaidi, Z and Jagdish, S (1999). In vitro percutaneous absorption enhancement of propranolol hydrochloride through porcine epidermis by terpenes/ethanol. 62: 359-366.
23. Bonina, F.P., Carellii, V., Cols, G.D., Montenegro, L. and Nannipieri, E. (1993). Vehicle effects on in vitro skin permeation of and stratum corneum affinity for model drugs caffeine and testosterone. Int. J. Pharm, 100: 41-47.
24. Fan, L.T. and Singh, S.K. (1989). Controlled release: A quantitative treatment. Springer-Verlag, New York. 13-56, 85-129.
25. Vamshi Vishnu, Y., Ramesh, G., Chandrasekhar, K., Bhanoji rao, M.E. and Madhusudan Rao, Y. (2007). Development and in vitro evaluation of buccoadhesive carvedilol tablets Acta Pharm, 57:185-197.
26. Rama Rao, P. and Diwan, P.V. (1998). Formulation and in vitro evaluation of polymeric films of diltiazem hydrochloride and indomethacin for transdermal administration. Drug Dev. Ind. Pharm, 24: 327-336.
27. Rigg, P.C. and Barry, B.W. (1990). Shed snake skin and hairless mouse skin as model membranes for human skin during permeation studies. J. Invest. Dermatol, 94: 234-240.
28. Valenta, C. and Wedding, C. (1997). Effects of penetration enhancers on the in vitro percutaneous absorption of progesterone. J. Pharm. Phamacol, 49: 955-959.